Array/VentiRx Partner On Toll-Like Receptor Drugs In Oncology, Allergy

Through a licensing agreement, VentiRx gains rights to Array’s TLR program containing several development candidates

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet